drugset / Trial / NCT01034982
AZD9668 Relative Bioavailability
RandomizedSingle-groupOpen-label
Summary
The study is designed to investigate the pharmacokinetic behaviour of the free base formulation of AZD9668. The study will compared the relative bioavailability of the free base formulation at two different dose levels compared to the tosylate salt formulation.
Timeline
- Start
- 2009-11
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alvelestat | Small molecule | 20 mg | Oral |
| Subject | Alvelestat | Small molecule | 60 mg | Oral |